Pfizer, Merck, J&J to release cancer drug data

Pfizer, Merck, J&J to release cancer drug data

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American … Read more

What to know about human cases, vaccines

What to know about human cases, vaccines

Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low.  A strain of bird flu called H5N1 has been confirmed … Read more

Pfizer announces new cost cutting program

Pfizer announces new cost cutting program

Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it works to rebound from the rapid decline of its Covid business.  The announcement is in addition … Read more

AstraZeneca to boost revenue, release new medicines by 2030

AstraZeneca to boost revenue, release new medicines by 2030

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. “We have … Read more

Novavax stock jumps on Sanofi Covid vaccine deal

Novavax stock jumps on Sanofi Covid vaccine deal

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company’s new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the struggling vaccine maker. Novavax’s stock … Read more

Moderna says RSV vaccine FDA approval delayed to end of May

Moderna says RSV vaccine FDA approval delayed to end of May

Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency … Read more

Novavax and Sanofi to commercialize Covid vaccine, develop combo shots

Novavax and Sanofi to commercialize Covid vaccine, develop combo shots

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid … Read more

Pfizer (PFE) earnings Q1 2024

Pfizer (PFE) earnings Q1 2024

Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefitting from its broad cost-cutting program and strong sales of its non-Covid products. The company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year, up from … Read more

Eli Lilly (LLY) says it can overcome high-quality problem of too much demand

Eli Lilly (LLY) says it can overcome high-quality problem of too much demand

Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue in the three months ended March … Read more

Fed meeting and Apple, Amazon, Eli Lilly report

Fed meeting and Apple, Amazon, Eli Lilly report

CNBC’s Jim Cramer on Friday walked investors through next week on Wall Street. It’s a week jam-packed with notable events, including earnings from Apple, Amazon and Eli Lilly. He also advised investors to pay attention to Wednesday’s Federal Reserve meeting and Friday’s employment figures from the Department of Labor. “We have to run such a … Read more